EpCAM/TROP1 Antibody (G8.8R) [Alexa Fluor® 750] Summary
Recombinant Monoclonal Antibody.
TE-71 Thymic epithelial cell line
Detects mouse EpCAM/TROP-1.
IgG2a
Monoclonal
Rat
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Flow Cytometry 0.25-1 ug/10^6 cells
Packaging, Storage & Formulations
Store the unopened product at 2 – 8 °C. Do not use past expiration date.
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for EpCAM/TROP1 Antibody (G8.8R) [Alexa Fluor® 750]
- 17-1A
- 323/A3
- ACSTD1
- antigen identified by monoclonal AUA1
- CD326 antigen
- CD326
- Cell surface glycoprotein Trop-1
- chromosome 4, surface marker (35kD glycoprotein)
- DIAR5
- EGP
- EGP-2
- EGP314
- EGP40
- EpCAM
- epithelial cell adhesion molecule
- Epithelial cell surface antigen
- Epithelial glycoprotein 314
- Epithelial glycoprotein
- ESA
- GA733-2
- GA733-2EGP34
- gp40
- hEGP314
- HNPCC8
- KS 1/4 antigen
- KS1/4
- KSAHEA125
- M1S2
- M4S1
- M4S1Ly74
- Major gastrointestinal tumor-associated protein GA733-2
- MIC18MH99
- MOC31
- TACST-1
- TACSTD1
- TROP1
- TROP1CD326
- Tumor-associated calcium signal transducer 1CO-17A
Background
Epithelial Cellular AdhesionMolecule (EpCAM), also known as EGP314 (Epithelial glycoprotein 314), TACSTD1(tumor-associated calcium signal transducer 1) and CD326 is a 292 amino acid(aa), 40 kDa transmembrane glycoprotein composed of a 243 aa extracellulardomain with two epidermal-growth-factor-like (EGF-like) repeats within thecysteine-rich N-terminal region, a 23 aa transmembrane domain, and a 26 aacytoplasmic domain. Human and mouse EpCAM share 82% aa sequence identity.During embryonic development, EpCAM is detected in fetal lung, kidney, liver,pancreas, skin, and germ cells. EpCAM has been shown function as a homophilicCa2+ independent adhesion molecule (1). Homophilic adhesion viaEpCAM requires the interaction of both EGF-like repeats, with the firstEGF-like repeat mediating reciprocal interaction between EpCAM molecules onopposing cells, while the second repeat is involved in lateral interaction ofEpCAM. Lateral interaction of EpCAM lead to the formation of dimers andtetramers (2). During homophilic adhesion the cytoplasmic tail of EpCAMinteracts with the actin cytoskeleton via a direct association alpha -actinin (3).
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets : Aurora Kinase inhibitors